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Sarcoma de Kaposi clássico fatal
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Abstract: First described in 1872, Kaposi's sarcoma is defined as a rare multifocal tumor that originates in the
endothelial cells and presents with cutaneous and extracutaneous manifestations. The classic form is most common
in elderly men and progression is slow.  This tumor responds well to chemotherapy and radiotherapy.  This report
describes a classic case of Kaposi's sarcoma in a woman with skin and visceral manifestations in whom the disease
rapidly progressed to a fatal outcome.
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Resumo: Descrito em 1872, o sarcoma de Kaposi é neoplasia multicêntrica rara originária de células endoteliais com
manifestação cutânea e extracutânea. A forma clássica é muito mais frequente em homens idosos, com evolução pro-
longada e boa resposta a quimioterapia e radioterapia. Apresentaremos um caso de sarcoma de Kaposi clássico com
comprometimento cutâneo e visceral em paciente do sexo feminino com rápida evolução fatal.
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INTRODUCTION
Kaposi’s sarcoma (KS) is a rare tumor described
by Moritz Kaposi as a benign disease of the elderly.
Four clinical forms are currently recognized: classic
KS, African endemic KS, iatrogenic transplant-related
KS and epidemic AIDS-associated KS.  Although the
four types have different forms of progression, they
have similar phenotypical characteristics.
Classic KS is more common in elderly males of
Jewish, European or Mediterranean descent. 1,2 Two
studies conducted in Italy, for example, have con-
firmed the difference in incidence rates between men
and women, Dal Maso et al. reporting a male-to female
ratio of 1 to 0.4 per 100,000 inhabitants/year. 3,4
This tumor is characterized by slowly progress-
ing, purple macules on the distal portion of the limbs
that may acquire nodular or tumoral characteristics as
the disease progresses.  Dissemination to internal
organs may occur in the more advanced forms.
This report describes an aggressive case of clas-
sic KS with rapid progression and fatal outcome in a
female patient from the northeast of Brazil.
CASE REPORT
A 61-year old, white, female patient from the
Brazilian state of Pernambuco, who had been living in
the state of São Paulo for more than 30 years, sought
medical attention for lesions that had appeared
around 18 months previously on her right lower limb.
She had a history of arterial hypertension.
She had begun treatment with a rheumatologist
four months previously based on a diagnostic hypothe-
sis of erythema nodosum and had used hydroxychloro-
quine and 20 mg of prednisone daily.  She reported a
progressive increase in the lesions over the previous
two months, with dissemination to the left leg and the
presence of purulent secretion and a fetid odor.
Initial physical examination revealed single and
confluent papules, nodules and tumoral lesions form-
ing infiltrated plaques and affecting almost the entire
right lower limb and the distal third of the left lower
limb.  There was a hardened edema over the entire
right lower limb, intense exudation and a purulent
secretion in lesions on the homolateral foot, in addi-
tion to areas of necrosis on both feet (Figures 1 and
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2).  A violet-colored nodule with a purple halo was
also found on the left chest region (Figure 3), which
was reported by the patient to have appeared within
the last week.  While in hospital, a new purplish, ery-
thematous lesion appeared in the right retroauricular
area.  No lesions were found in the oral cavity, and
there were no adenomegaly, hepatomegaly or
splenomegaly.  
Histopathology of the lesion on the left chest
region showed a morphological appearance compati-
ble with a KS lesion in an initial phase, with a predom-
ination of vascular channels and discretely atypical
proliferations of capillary vessels and areas without
nuclear atypia (Figure 4).   Histopathology of the
lesion on the patient’s right leg showed morphology
characteristic of the more advanced phase of the dis-
ease, with an intense proliferation of cells, atypical
fusiform nuclei and mitotic figures involving vessels
and vascular channels (Figure 5).
Bronchoscopy revealed wine-colored lesions
bordered by accentuated hyperemic lines in the prox-
imal and mid trachea, suggestive of Kaposi’s sarcoma.
Serology for HIV and hepatitis B and C was neg-
ative.  Laboratory workup showed creatinine 4.1 and
urea 219.  Ultrasonographic evaluation of the kidneys
revealed signs of parenchymatous nephritis and a
bilateral increase in the renal cortex.  The patient was
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FIGURE 1: Lesions of Kaposi's sarcoma on the lower limbs:
papules, nodules, tumoral lesions and infiltrative plaques.  Intense
exudation, purulent secretion and areas of necrosis
FIGURE 3: Recent lesion of Kaposi's sarcoma:  violet-colored nod-
ule with a purplish halo on the left side of the patient's chest
FIGURE 2: Detail of the lesions of Kaposi's sarcoma on the right leg:
multiple nodules and hardened purple erythematous papules
FIGURE 4: Left intercostal lesion: discretely atypical proliferation of
vascular channels and capillary vessels and areas with no nuclear
atypia (HE; magnification 100x).  Note the extravasated erythro-
cytes in the middle of vascular channels (HE; magnification 200x)
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being followed up by a nephrology team under the
hypothesis of acute on chronic renal failure.  Kidney
biopsy was planned but was not performed.  No sig-
nificant abnormalities were found in any of the other
tests performed.
The patient remained in hospital for only ten
days and, despite the use of wide spectrum antibiotics
throughout the entire duration of her hospitalization,
she developed a severe skin infection, which pro-
gressed to septic shock and death.  It was not, there-
fore, possible to perform clinical staging of the tumor
or initiate chemotherapy.
DISCUSSION
KS is a multifocal endothelial tumor of low
malignant potential.  It was considered rare until the
beginning of the AIDS epidemic.  From 1981 onwards,
its incidence increased considerably, principally in
male patients who have sex with men (AIDS-associat-
ed Kaposi’s sarcoma).  In 1994, the involvement of a
virus of the herpes group (HHV-8 or KSHV) in the
etiopathogeny of KS was identified. 5 More recent
studies have shown three factors most commonly
involved in the etiopathogeny of this disease: infec-
tion by the human immunodeficiency virus (HIV),
HHV-8 infection and the role of cytokines. 1,6,7 In HIV-
positive patients, the introduction of combined, high-
ly active antiretroviral therapy (HAART) resulted in a
significant reduction in the number of new cases of
epidemic KS from 1996 onwards. 8-10
Endemic KS occurs throughout all of equatorial
Africa, particularly in sub-Saharan Africa.  It affects
children and adults, predominantly males, and is not
associated with immunodeficiency.  Its clinical variants
are: nodular, florid, infiltrative and lymphadenopathic
KS.  In children, the condition tends to be fatal.
Patients undergoing immunosuppressive thera-
py, particularly solid organ transplant patients, have
an increased risk of developing iatrogenic KS, which,
according to Tesari et al. may reach a hundred-fold. 11
It occurs typically in the first two years of treatment
with immunosuppressive drugs and clinical severity is
generally proportional to the degree of immunosup-
pression.  Its principal characteristic is the reversibili-
ty of the condition with suspension of the immuno-
suppressors.
Classic KS is a rare condition, which progresses
slowly and is benign.  It affects principally males of 40-
70 years of age. 1-4 Its incidence varies from region to
region, being more common in Italy, Greece, Turkey
and Israel.  In the case described here, it should be
emphasized that the patient was originally from the
northeastern region of Brazil and she reported no
family history of predecessors of Mediterranean or
Jewish descent.
Lesions typically start as purple macules in the
distal portion of the lower limbs, progressing very slow-
ly (over years or even decades) to nodules, plaques and
tumorous lesions.  Because they are multifocal, new
lesions may appear at other sites.  As the disease pro-
gresses, the lesions harden, becoming brown-colored
with an irregular surface.  Ulceration and perilesional
edema may be present.  The mucosa is affected in
around 15% of patients and the visceral form of the dis-
ease most commonly affects the lymph nodes and the
digestive tract; 12 however, the liver, lungs and heart may
also be affected, as well as other organs.  In the case
described here, the lesions were extremely aggressive.
In a little over a year, the lesions spread to cover almost
the entire right leg of the patient and lesions had also
appeared at distant sites.  In the ten days of hospitaliza-
tion in which the patient was followed up, progression
of the older lesions was noted, as well as the appear-
ance of a new retroauricular lesion.  Due to the severe
clinical condition of the patient, it was impossible to
evaluate the extent of the disease in the internal organs;
however, lesions were found in the lung, an unusual
site for a more indolent disease.
Histopathology findings vary in accordance
with the clinical stage of the lesions.  The initial KS
lesions (macules and plaques) are characterized by a
slight increase in dermal vessels with little endothelial
atypia, associated with surrounding hemosiderin dep-
osition.  This feature may be confused with granula-
tion tissue, which hampers histopathological diagno-
sis.  In the more advanced phases of the disease, cell
proliferation is numerically greater and has a fusiform
appearance, with the formation of irregular vascular
channels that may contain whole and degenerated
FIGURE 5: Lesion on the right leg:  intense cell proliferation, atypi-
cal fusiform nuclei and mitotic figures involving vessels and vascu-
lar channels (HE; magnification 100x).  Note the proliferation of
fusiform cells with nuclear atypia (HE, magnification 200x)
extravasated erythrocytes.  Mitotic activity is more
prominent.  The histopathological differences
between the distinct chronological and morphological
stages of the disease were clearly present in this case.
The response of KS to the various therapeutic
strategies is good. 13 For localized lesions, surgical
excision, cryotherapy and radiotherapy may be used.
For larger skin lesions, multiple lesions or those
affecting internal organs, systemic therapy may be
indicated.  Of these forms of treatment, chemothera-
py is used when the disease is disseminated, and is
effective both on skin and visceral lesions.  There are
various active chemotherapy agents with response
rates of around 60-80%, including the liposomal
anthracyclines (doxorubicin, daunorubicin), paclitax-
el, vinblastine and etoposide.  Immunotherapy with
interferon may be indicated in certain cases.
The present report described the case of a
female patient from the northeastern region of Brazil
with classic KS presenting with extensive skin and pul-
monary involvement.  Progression of the disease was
rapid, leading to a fatal outcome. 
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